Wednesday, May 25, 2011

RegenMD - Kensey Nash Acquires Assets of Synthes' Norian Subsidiary

     
    RegenMD    
   
Kensey Nash Acquires Assets of Synthes' Norian Subsidiary
May 24, 2011 at 6:08 PM
 
The addition of Norian's orthobiosurgery and other key biomaterial products should allow Kensey Nash to further its penetration into the regenerative medicine markets encompassing soft tissue surgical repair, orthopaedics, sports medicine, ...
See all stories on this topic »
   
   
Two Candidates Nominated to Lead California Stem Cell Agency
May 24, 2011 at 3:42 PM
 
by Greg Miller on 24 May 2011, 3:32 PM | Permanent Link | 0 Comments Southern California investor Jonathan Thomas and cardiologist turned entrepreneur Frank Litvack have been nominated to lead the California Institute of Regenerative Medicine (CIRM). ...
See all stories on this topic »
   
   
Nature Says CIRM Faces 'Stark Choice" in New Chairman
May 24, 2011 at 1:20 PM
 
   
   
Juventas' stem cell therapy shows promise in phase 1 study
May 24, 2011 at 1:16 PM
 
A phase 1 clinical trial has shown that Juventas Therapeutics' regenerative medicine therapy provides clinical benefit to heart failure patients. Phase 1 trials generally focus on safety, so the indication of clinical benefit is an encouraging sign for ...
See all stories on this topic »
   
   
A promising culture model for analyzing the interaction between adipose tissue and cardiomyocytes.
May 24, 2011 at 6:34 AM
 

A promising culture model for analyzing the interaction between adipose tissue and cardiomyocytes.

Endocrinology. 2011 Apr;152(4):1599-605

Authors: Anan M, Uchihashi K, Aoki S, Matsunobu A, Ootani A, Node K, Toda S

The heart has epicardial adipose tissue that produces adipokines and mesenchymal stem cells. Systemic adipose tissue is involved in the pathophysiology of obesity-related heart diseases. However, the method for analyzing the direct interaction between adipose tissue and cardiomyocytes has not been established. Here we show the novel model, using collagen gel coculture of adipose tissue fragments (ATFs) and HL-1 cardiomyocytes, and electron microscopy, immunohistochemistry, real-time RT-PCR, and ELISA. HL-1 cells formed a stratified layer on ATF-nonembedded gel, whereas they formed almost a monolayer on ATF-embedded gel. ATFs promoted the apoptosis, lipid accumulation, and fatty acid transport protein (FATP) expression of FATP4 and CD36 in HL-1 cells, whereas ATFs inhibited the growth and mRNA expression of myosin, troponin T, and atrial natriuretic peptide. Treatment of leptin (100 ng/ml) and adiponectin (10 μg/ml) neither replicated nor abolished the ATF-induced morphology of HL-1 cells, whereas that of FATP4 and CD36 antibodies (25 μg/ml) never abolished it. HL-1 cells prohibited the development of CD44+/CD105+ mesenchymal stem cell-like cells and lipid-laden preadipocytes from ATFs. HL-1 cells increased the production of adiponectin in ATFs, whereas they decreased that of leptin. The data indicate that our model actively creates adipose tissue-HL-1 cardiomyocyte interaction, suggesting first that ATFs may be related to the lipotoxiciy of HL-1 cells via unknown factors plus FATP4 and CD36 and second that HL-1 cells may help to retain the static state of ATFs, affecting adipokine secretion. Our model will serve to study adipose tissue-cardiomyocyte interaction and mechanisms of obesity-related lipotoxicity and heart diseases.

PMID: 21303960 [PubMed - indexed for MEDLINE]

   
   
Graphene used in biomedical applications can control the fate of stem cells
May 24, 2011 at 4:51 AM
 
The range of potentially ground-breaking therapies based on stem cells ranges from combating Alzheimer's Disease to regenerative medicine (see: "Nanotechnology based stem cell therapies for damaged heart muscles"). Key to the success of such therapies ...
See all stories on this topic »

Nanowerk LLC
   
   
Graphene used in biomedical applications can control the fate of stem cells
May 24, 2011 at 4:41 AM
 
Using these techniques, current tissue engineering approaches for example combine different scaffold materials with living cells to provide biological substitutes that can repair and eventually improve tissue functions. The downside of guiding cells ...
See all stories on this topic »

Nanowerk LLC
   
   
Two nominated to lead California stem cell agency
May 24, 2011 at 3:25 AM
 
The California Institute for Regenerative Medicine, created by California voters after then-President George W. Bush banned federally funded embryonic stem cell research, has been led for six years by the man who authored the legislation approved by ...
See all stories on this topic »
   
   
Minimal News Coverage on CIRM Chair Nominees
May 24, 2011 at 2:26 AM
 
   
     
 
This email was sent to agupta1213+termsc@gmail.com.
Delivered by Feed My Inbox
PO Box 682532 Franklin, TN 37068
Account Login
Unsubscribe Here Feed My Inbox
 
     

No comments: